首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Preparation of a novel starch-derived three-dimensional ordered macroporous carbon for improving the dissolution rate and oral bioavailability of water-insoluble drugs
【24h】

Preparation of a novel starch-derived three-dimensional ordered macroporous carbon for improving the dissolution rate and oral bioavailability of water-insoluble drugs

机译:新型淀粉衍生的三维有序大孔碳的制备,以提高水不溶性药物的溶出度和口服生物利用度

获取原文
获取原文并翻译 | 示例
           

摘要

In our study, soluble starch was applied as a novel carbon source for preparing three-dimensional ordered macroporous carbon (300MC) using monodisperse silica nanospheres as the hard template. The 3DOMC was used as an insoluble drug carrier when it was found that it could markedly improve the water solubility of felodipine (FOP). The structural features of 3DOMC were characterized by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The 3DOMC structure was found to have a higher drug loading than microporous and mesoporous structures, and the interconnected nanostructure effectively inhibited the formation of drug crystals. FOP, belonging to the Biopharmaceutics Classification System II (BCSII), was chosen as the model drug and was loaded into the 3DOMC structure by solvent evaporation. The state of FOP in the 3DOMC structure was characterized by powder X-ray diffractometry (PXRD), differential scanning calorimetry (DSC) and Fourier-transform infrared spectroscopy (FTIR). The results obtained showed that FDP was present in the pores in an amorphous or microcrystalline state. In vivo and in vitro experiments indicated that 300MC could significantly improve the drug dissolution rate, but the FDP-3DOMC self-made common tablets had the disadvantage of a burst effect. For this reason, osmotic pump technology was used to control the drug release rate. We developed a potentially useful insoluble drug carrier for pharmaceutical applications. (C) 2015 Elsevier B.V. All rights reserved.
机译:在我们的研究中,可溶性淀粉被用作一种新颖的碳源,以单分散二氧化硅纳米球为硬模板制备三维有序大孔碳(300MC)。当发现3DOMC可以显着改善非洛地平(FOP)的水溶性时,它被用作不溶性药物载体。通过扫描电子显微镜(SEM)和透射电子显微镜(TEM)表征了3DOMC的结构特征。发现3DOMC结构比微孔和中孔结构具有更高的载药量,并且相互连接的纳米结构有效地抑制了药物晶体的形成。选择属于生物制药分类系统II(BCSII)的FOP作为模型药物,并通过溶剂蒸发将其加载到3DOMC结构中。 FDOM在3DOMC结构中的状态通过粉末X射线衍射(PXRD),差示扫描量热法(DSC)和傅立叶变换红外光谱(FTIR)进行表征。所得结果表明,FDP以无定形或微晶态存在于孔中。体内外实验表明300MC可以显着提高药物的溶出度,但FDP-3DOMC自制普通片剂具有爆破作用的缺点。因此,使用渗透泵技术来控制药物释放速率。我们开发了一种潜在有用的不溶性药物载体,可用于药物应用。 (C)2015 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号